Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPT1 pseudogene 4 (TPT1P4) is a processed pseudogene of the TPT1 (Tumor Protein, Translationally-Controlled 1) gene[4]. Pseudogenes are genomic DNA sequences similar to normal genes but typically are non-functional; they usually do not encode functional proteins due to mutations or lack of regulatory elements. Some pseudogenes can be transcribed and may have regulatory or RNA-based functions, though this has not been demonstrated for TPT1P4. Promoter activity and transcription for pseudogenes in the TPT1 family have been documented, but they are not established drug targets[4]. The protein-coding TPT1 is involved in cell proliferation, apoptosis, and cancer biology, but TPT1P4 is not considered to have a role as a receptor, enzyme, or therapeutic target. Summary: - TPT1P4 is a pseudogene, not a pharmacologically targetable molecule. - It is not a recognized receptor, enzyme, transporter, or target. - No therapeutic, biomarker, or mechanistic data links TPT1P4 to druggable biology or disease. - The entry is "incorrect" as a target in a therapeutic context, as it is not a targetable molecule[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPT1 pseudogene 4 (TPT1P4).